Research Center for Nutrition and Food Safety, Institute of Military Preventive Medicine, Third Military Medical University, Chongqing Key Laboratory of Nutrition and Food Safety, Chongqing Medical Nutrition Research Center, 400038, Chongqing, People's Republic of China.
Int J Obes (Lond). 2020 Aug;44(8):1678-1690. doi: 10.1038/s41366-020-0566-y. Epub 2020 Mar 17.
Current evidence has linked dietary resveratrol (RSV) intake to the activation of brown adipose tissue (BAT) and induction of white adipose tissue (WAT) browning, which may be a potential means of improving glucose homeostasis. However, the underlying mechanisms remain unclear.
A diet containing RSV was fed to db/db mice for 10 weeks, following which the body weight, adipose tissue accumulation, bile acid (BA) profiles, and markers of BA metabolism were analyzed. Oral glucose tolerance testing, immunohistochemistry, and gut microbiota sequencing were also performed.
RSV intervention improved glucose homeostasis in db/db mice, which was linked to the enhanced BAT activity and WAT browning. Moreover, RSV-treated mice exhibited altered plasma and fecal BA compositions and significant remodeling of the gut microbiota, the latter confirmed by a higher level of lithocholic acid (LCA) in the plasma and feces. LCA was identified to be the agonist of Takeda G-protein coupled receptor 5 (TGR5), which mediated the BAT activation and WAT browning by upregulating uncoupling protein 1 (UCP1) expression. Furthermore, depletion of the gut microbiota using antibiotics partially abolished the beneficial effects of RSV against glucose intolerance. Finally, microbiota transplantation experiments demonstrated that the RSV-induced beneficial effects were transferable, indicating that these effects were largely dependent on the gut microbiota.
These data indicate that RSV administration improves glucose homeostasis by enhancing BAT activation and WAT browning, a mechanism that might partially be mediated by the gut microbiota-BA-TGR5/UCP1 pathway.
现有证据表明,膳食白藜芦醇(RSV)的摄入与棕色脂肪组织(BAT)的激活和白色脂肪组织(WAT)的褐变有关,这可能是改善葡萄糖稳态的一种潜在手段。然而,其潜在机制尚不清楚。
用含有 RSV 的饮食喂养 db/db 小鼠 10 周,分析体重、脂肪组织积累、胆汁酸(BA)谱和 BA 代谢标志物。还进行了口服葡萄糖耐量试验、免疫组织化学和肠道微生物组测序。
RSV 干预改善了 db/db 小鼠的葡萄糖稳态,这与增强的 BAT 活性和 WAT 褐变有关。此外,RSV 处理的小鼠表现出改变的血浆和粪便 BA 组成以及肠道微生物组的显著重塑,后者通过血浆和粪便中更高水平的石胆酸(LCA)得到证实。LCA 被鉴定为 Takeda G 蛋白偶联受体 5(TGR5)的激动剂,通过上调解偶联蛋白 1(UCP1)的表达来介导 BAT 激活和 WAT 褐变。此外,使用抗生素耗尽肠道微生物群部分消除了 RSV 对葡萄糖不耐受的有益作用。最后,微生物群移植实验表明,RSV 诱导的有益效果是可传递的,表明这些效果在很大程度上依赖于肠道微生物群。
这些数据表明,RSV 给药通过增强 BAT 激活和 WAT 褐变来改善葡萄糖稳态,其机制可能部分通过肠道微生物群-BA-TGR5/UCP1 途径介导。